Wide Ranks

DMAC

DiaMedica Therapeutics Inc.

5.21

Top Statistics
Market Cap 222 M Forward PE -6.59 Revenue Growth 0.00 %
Current Ratio 17.82 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -5.48 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 54 M Total Cash Per Share 1.26 Total Debt 388000
Total Debt To Equity 0.7260 Current Ratio 17.82 Book Value Per Share 1.34
All Measures
Short Ratio 388.00 % Message Board Id finmb_4382397 Shares Short Prior Month 152275
Return On Equity -0.3518 City Minneapolis Uuid b3b6442c-de29-30ba-912e-479d62e5fd59
Previous Close 5.08 First Trade Date Epoch Utc 1 B Book Value 1.34
Beta 1.46 Total Debt 388000 Volume 195260
Price To Book 3.87 Last Split Date 1 B Fifty Two Week Low 2.14
Total Cash Per Share 1.26 Shares Short Previous Month Date 1 B Target Median Price 7.00
Max Age 86400 Recommendation Mean 1.25 Sand P52 Week Change 0.3133
Target Mean Price 7.00 Net Income To Common -19902000 Short Percent Of Float 0.0059
Implied Shares Outstanding 42 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 205690 Average Volume10days 205690 Total Cash 54 M
Next Fiscal Year End 1 B Held Percent Insiders 0.2622 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 5.08
Target Low Price 6.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 4.33
Open 5.07 Free Cashflow -11141000 State MN
Dividend Yield 0.00 % Return On Assets -0.2354 Time Zone Short Name EST
Trailing Eps -0.5600 Day Low 5.07 Address1 301 Carlson Parkway
Shares Outstanding 42 M Price Hint 2 Target High Price 8.00
Website https://www.diamedica.com 52 Week Change 1.14 Average Volume 76225
Forward Eps -0.7400 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 1763.10 % Last Split Factor 1:20 Regular Market Day High 5.56
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 0.7260
Fifty Two Week High 5.56 Day High 5.56 Shares Short 175551
Regular Market Open 5.07 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0041 Operating Cashflow -19781000
Currency USD Time Zone Full Name America/New_York Market Cap 222 M
Is_nasdaq_100 False Zip 55305 Quote Type EQUITY
Industry Biotechnology Long Name DiaMedica Therapeutics Inc. Regular Market Day Low 5.07
Held Percent Institutions 0.3161 Current Price 5.21 Address2 Suite 210
Enterprise To Ebitda -5.48 Financial Currency USD Current Ratio 17.82
Industry Disp Biotechnology Number Of Analyst Opinions 4 Country United States
Float Shares 26 M Two Hundred Day Average 3.41 Enterprise Value 122 M
Forward PE -6.59 Regular Market Volume 195260 Ebitda -22350000
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke.

Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase II/III trials for the treatment of acute ischemic stroke, as well as that is in Phase 2 to treat cardio-renal disease.

The company also develops DM300, which is in preclinical stage for the treatment of severe inflammatory diseases.

In addition, it develops treatment for neurological disease.

The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016.

DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.